Dawn Health and Merck partner to create a 2-year digital platform using AI for 40,000+ Growth Hormone Disorder patients across 40+ countries.

Dawn Health and Merck partner to create a user-centric digital platform over 2 years, aiming to improve lives of 40,000+ Growth Hormone Disorder patients across 40+ countries. AI technologies will offer growth predictions and personalization, enhancing user experience and treatment outcomes. The platform supports patients, caregivers, and healthcare professionals, focusing on patient-centricity for an intuitive, engaging product.